Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,357 | 23 | 96.1% |
| Education | $94.76 | 3 | 3.9% |
| Unspecified | $0 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $737.09 | 9 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $368.85 | 4 | $0 (2019) |
| Kyowa Kirin, Inc. | $249.99 | 2 | $0 (2021) |
| Amgen Inc. | $246.78 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $225.40 | 2 | $0 (2019) |
| Lilly USA, LLC | $187.84 | 3 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $117.40 | 1 | $0 (2017) |
| Phathom Pharmaceuticals, Inc. | $112.30 | 1 | $0 (2024) |
| Aidoc Medical Ltd | $106.00 | 2 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $100.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.30 | 2 | Phathom Pharmaceuticals, Inc. ($112.30) |
| 2021 | $124.99 | 2 | Kyowa Kirin, Inc. ($124.99) |
| 2019 | $645.66 | 7 | Kyowa Kirin, Inc. ($125.00) |
| 2018 | $706.40 | 8 | Sunovion Pharmaceuticals Inc. ($251.79) |
| 2017 | $762.30 | 8 | Janssen Pharmaceuticals, Inc ($398.12) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $112.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: PSYCHIATRY | ||||||
| 08/11/2021 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ADENOSINE A2A RECEPTORS | ||||||
| 2021 | Aidoc Medical Ltd | — | — | — | $0.00 | Ownership |
| 12/01/2019 | Aidoc Medical Ltd | Briefcase (Device) | Food and Beverage | Cash or cash equivalent | $106.00 | General |
| Category: Radiology | ||||||
| 11/20/2019 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ADENOSINE A2A RECEPTORS | ||||||
| 07/17/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $117.06 | General |
| Category: RESPIRATORY | ||||||
| 04/24/2019 | Lilly USA, LLC | TRULICITY (Drug) | Education | In-kind items and services | $75.10 | General |
| Category: Diabetes | ||||||
| 04/24/2019 | Lilly USA, LLC | TRULICITY (Drug) | Education | In-kind items and services | $15.02 | General |
| Category: Diabetes | ||||||
| 03/20/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $106.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/20/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $101.46 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/03/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $119.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 08/13/2018 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: Respiratory | ||||||
| 05/16/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $119.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/10/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $9.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2018 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $97.72 | General |
| Category: Diabetes | ||||||
| 03/28/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $108.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2018 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 11/17/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Education | In-kind items and services | $4.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $124.76 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $125.91 | General |
| Category: Endocrinology | ||||||
| 06/14/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $121.75 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $117.40 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 394 | 1,401 | $203,484 | $132,198 |
| 2022 | 3 | 510 | 1,611 | $237,269 | $135,807 |
| 2021 | 3 | 602 | 1,565 | $237,410 | $138,897 |
| 2020 | 4 | 894 | 2,741 | $398,630 | $223,557 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 213 | 1,201 | $155,830 | $102,377 | 65.7% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 181 | 200 | $47,654 | $29,821 | 62.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 268 | 1,341 | $173,995 | $99,217 | 57.0% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 223 | 247 | $58,853 | $34,028 | 57.8% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 19 | 23 | $4,421 | $2,561 | 57.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 307 | 1,237 | $160,501 | $93,595 | 58.3% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 273 | 301 | $71,719 | $42,212 | 58.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 22 | 27 | $5,190 | $3,090 | 59.5% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 463 | 2,273 | $294,922 | $164,371 | 55.7% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 363 | 386 | $91,972 | $52,488 | 57.1% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 33 | 39 | $7,497 | $4,350 | 58.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 35 | 43 | $4,239 | $2,348 | 55.4% |
About Dr. Daniel Raskind, MD
Dr. Daniel Raskind, MD is a Geriatric Medicine healthcare provider based in Bellevue, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518034834.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Raskind, MD has received a total of $2,452 in payments from pharmaceutical and medical device companies, with $212.30 received in 2024. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,357).
As a Medicare-enrolled provider, Raskind has provided services to 2,400 Medicare beneficiaries, totaling 7,318 services with total Medicare billing of $630,459. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Location Bellevue, WA
- Active Since 11/30/2006
- Last Updated 01/28/2010
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1518034834
Products in Payments
- XARELTO (Drug) $576.82
- NOURIANZ (Drug) $249.99
- Prolia (Biological) $246.78
- LONHALA MAGNAIR (Drug) $243.85
- ENTRESTO (Drug) $225.40
- TRULICITY (Drug) $187.84
- INVOKANA (Drug) $160.27
- UTIBRON (Drug) $125.00
- ELIQUIS (Drug) $117.40
- VOQUEZNA (Drug) $112.30
- Briefcase (Device) $106.00
- REXULTI (Drug) $100.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Bellevue
Richard Kaner, M.d, M.D
Geriatric Medicine — Payments: $8,374
Dr. Benjamin Pinto, M.d, M.D
Geriatric Medicine — Payments: $1,913
Lacee Meyer, Arnp, ARNP
Geriatric Medicine — Payments: $1,841
Dr. Henry Williams, Md, MD
Geriatric Medicine — Payments: $60.92
Janice L Bishop, M.d, M.D
Geriatric Medicine — Payments: $21.56